A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Recruiting · NCT06971614 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC | Nonmuscle-invasive Bladder Cancer | Recruiting | Phase 2 | 2026-08-18 | NCT06971614 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ImmVira Pharma Co. Ltd | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advent Health Medical Group Urology | Orlando | United States | 1 |
| Allegheny Health Network | Pittsburgh | United States | 35 |
| Carolina Urologic Research Center | Myrtle Beach | United States | 55 |
| East Valley Urology Center | Queen Creek | United States | 1 |
| Florida Urology Partners, LLP | Tampa | United States | 2 |
| Helios Clinical Research | Middleburg Heights | United States | 2 |
| Rutgers Cancer Institute | New Brunswick | United States | 41 |
| Tower Urology | Los Angeles | United States | 9 |
| University of Cincinnati Medical Center | Cincinnati | United States | 27 |